Furthermore, compared with the MLP models, MD-AD reduced the prediction error by 7% for CERAD score, 13% for Braak stage, 7% for NPs, 25% for tangles, 10% for Aβ IHC, and 14% for τ IHC (Fig. 2a). This evidence concerns the gene TBXT and Alzheimer disease.